Clinical trial
An Observational Study to Evaluate Immune Response to Covid-19 Vaccines, Infections and Immune Treatments in People With Multiple Sclerosis
NCT05269888 is registered in ClinicalTrials.gov with University Hospitals of North Midlands NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study to Evaluate Immune Response to Covid-19 Vaccines, Infections and Immune Treatments in People With Multiple Sclerosis
- Lead sponsor
- University Hospitals of North Midlands NHS Trust
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- February 16, 2022
- Completion date
- December 30, 2025
- Enrollment
- 240 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.